Skip to NavigationSkip to content

FT Global Pharmaceutical and Biotechnology Conference

Published date: 
28/06/2017

The FT Global Pharmaceutical and Biotechnology Conference, now in its 35th successful year brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry, and the business models and transformation strategies that will be needed to survive and thrive in this new era of unprecedented disruption and uncertainty.

 

Speakers include:

Flemming Ornskov, Chief Executive Officer, Shire

Arie Belldegrun, Founder, Executive Chairman, Chief Executive Officer and President,

 Kite Pharma

Rod MacKenzie, Executive Vice President, Chief Development Officer, Pfizer

Bélén Garijo, Member of the Board and CEO, Healthcare, The Merck Group

Bahija Jallal, Executive Vice President, AstraZeneca and Head , MedImmune

Hervé Hoppenot, President and Chief Executive Officer, Incyte Corp

Vivek Ramaswamy, Chief Executive Officer, Roivant Sciences

José Luis Molinuevo, Scientific Director, Barcelona Beta Brain Research Centre, Pasqual Maragall Foundation

Lihi Segal, Co-Founder & CEO, DayTwo